Key Highlights

  • SELLAS Life Sciences (NASDAQ:SLS) fell 15% to 16% on October 28, 2026 after saying its REGAL trial reached the event count for final analysis, with results due this quarter, which ends December 31, 2026.
  • CoStar Group (NASDAQ:CSGP) fell 14% to 15% on October 28, 2026 even though third-quarter revenue reached USD 952 million, up 14%. One account says guidance was raised and another says it was weak.
  • Landstar System (NASDAQ:LSTR) fell about 17% on October 28, 2026 even though revenue rose 25%. One account points to insurance and claims costs hitting earnings per share. C.H. Robinson fell 11% with no reason found.
  • LPL Financial (NASDAQ:LPLA) fell 15.2% on October 28, 2026, and no company announcement or analyst note explaining the decline was found. Baker Hughes fell 7.2%, Banco Santander 6.1% and Garmin 5.7% the same day.

SELLAS Life Sciences (NASDAQ:SLS): Trial readout within about two months

SELLAS Life Sciences (NASDAQ:SLS) said in a company release that the REGAL trial had reached the number of events required for final analysis, and that results are expected this quarter. Published market data show the stock fell 15% to 16% on October 28, 2026. The release itself did not report efficacy, so the drop cannot be tied to any data. It is also not stated in the material reviewed whether the company gave a more precise date than this quarter. Investors therefore face a fixed deadline without knowing the outcome, which is why the shares can move sharply on the announcement alone, in either direction, before any result is public. In an event-driven trial, the statistical analysis is triggered by a prespecified number of events, such as deaths, instead of by a calendar date. Once the count is reached, the dataset is locked and independent statisticians compare the treatment and control arms. The step also removes the long wait that normally supports a share price, because the open question becomes a near-term binary test. One reading, offered as interpretation and not as a finding, is that some holders sold into the news to avoid the readout risk, though no confirmed reason for the decline was found.

CoStar Group (NASDAQ:CSGP): Growth with a double-digit fall

CoStar Group (NASDAQ:CSGP) reported third-quarter revenue of USD 952 million, up 14%, according to the company release, and its shares fell 14% to 15% on October 28, 2026. Reversing the growth rate, the prior-year quarter was about USD 835 million, simple arithmetic on published numbers. The material reviewed did not give earnings per share, margins, cash flow or consensus estimates, so it is unclear whether the quarter beat or missed expectations. The mismatch between solid growth and a steep fall usually means something other than headline revenue disappointed, which makes the reaction harder to explain from the numbers alone. Without consensus numbers, it is not possible to say whether the market saw this as a shortfall. One account says CoStar Group (NASDAQ:CSGP) raised full-year guidance, while another points to weak revenue guidance. Guidance is management's forecast for future results, and markets often react more to a change in that forecast than to the quarter just reported. A raised full-year figure could still imply a slower fourth quarter, which is one way both descriptions might coexist, though that is conjecture. The only reliable way to settle it is to read the company release and guidance schedule directly, which was not available in the material reviewed.

Landstar System (NASDAQ:LSTR): Revenue up 25% but earnings hit

Landstar System (NASDAQ:LSTR) shares fell about 17% on October 28, 2026, according to published market data, after a quarter in which revenue rose 25%. One account attributes the fall to insurance and claims costs that hit earnings per share, which means the cost of accidents, cargo claims and insurance premiums grew faster than revenue. The material reviewed gave no dollar figures for those costs, earnings per share, margins or consensus estimates, so the size of the miss is unknown. The headline contrast, strong sales and a steep drop, shows how much investors focus on profit conversion in freight. Freight brokers and agent networks can also see revenue rise from higher pass-through freight rates without a matching rise in profit, so the 25% figure alone says little about earnings quality. Freight and logistics companies carry liability for accidents and damaged goods, and they buy insurance or self-insure up to certain limits. When claims rise, the expense lands in the income statement in the quarter the claims are recognised, which can cut operating profit sharply. Landstar System (NASDAQ:LSTR) operates largely through independent agents and owner-operators, a structure that keeps fixed costs low, but claims are still a risk. Revenue growth of 25% can come from higher volumes or higher freight rates, and the material reviewed did not say which.

LPL Financial (NASDAQ:LPLA): No explanation found

Published market data show LPL Financial (NASDAQ:LPLA) down 15.2% on October 28, 2026, the largest of a group of decliners with no explanation found. Tickers EDU and ZWS fell 12.5% and 11.5%. They appear as tickers only in the data reviewed, so their company names and exchanges are not confirmed here and they carry no tags. Baker Hughes fell 7.2%, Banco Santander 6.1% and Garmin 5.7%. The companies span wealth management, education, water products, energy services, banking and consumer devices, which suggests no single industry story ties the moves together. Because none of the moves came with a verified explanation, this article reports only the price changes that published market data show. A sharp fall with no announcement can have several mechanisms, none confirmed here. Results or guidance released after the prior close may not have been captured. An analyst downgrade, a large block sale, index changes or a shift in funding costs can move a stock without a company release. For LPL Financial (NASDAQ:LPLA), a brokerage platform whose revenue links to client assets and interest rates, market direction and the rate backdrop can matter.

Where Things Stand

The answer is that the fall is certain and the cause is not. SELLAS Life Sciences (NASDAQ:SLS) faces a near-term trial readout. CoStar Group (NASDAQ:CSGP) has conflicting guidance accounts. Landstar System (NASDAQ:LSTR) has a single-account explanation about claims costs. LPL Financial (NASDAQ:LPLA) has no explanation at all. The next catalysts are the SELLAS results announcement, the CoStar guidance schedule, the Landstar cost breakdown and any LPL disclosure. This is not investment advice.